Cramer: This biotech stock could be worth over $100 billion on an FDA approval

Category: elite-pharma-ihub High Quality

About This Video

Watch "Cramer: This biotech stock could be worth over $100 billion on an FDA approval" - a great video from the elite-pharma-ihub category. Enjoy high-quality streaming with our advanced video player.

Enjoying ImgLint?

If you're enjoying our platform, please consider sharing it with friends or reaching out to us with feedback. Your support helps us grow!

Contact